Objective: To evaluate the effects of azimilide and ambasilide on the biophysical properties of the human-ether-a-go-go-related (HERG) channel. Methods: HERG was stably transfected into Chinese hamster ovary (CHO-K1) cells and currents were measured using a whole cell, voltage-clamp technique. Results: Azimilide had a 'dual effect', inhibiting current at voltage steps above 240 mV and augmenting current at 240 and 250 mV. Tail current inhibition following a step to 130 mV did not vary with temperature (IC 610 nM 50 at 228C and 560 nM at 378C). The agonist effect at 250 mV was concentration-dependent and correlated with a hyperpolarizing shift in the V of activation (r50.98, P,0.05). Time constants of inactivation were faster and there was a 210 mV shift in the V of steady 
Introduction
amiodarone, azimilide and ambasilide) may confer greater efficacy and safety [2, 3] . Class III antiarrhythmic drugs prolong repolarization
Azimilide is an antiarrhythmic drug with predominant principally via inhibition of the rapidly activating comclass III activity, which is chemically unrelated to the ponent of the delayed rectifier channel (I ). The reverse widely-studied methanesulphonanilide I -blocking drugs.
Kr K frequency-dependent prolongation of action potential duraIt is an equipotent inhibitor of I and I , and has Ks Kr tion (APD) and effective refractory period (ERP), exsignificant activity against other cardiac ion channels hibited by a number of these agents may reduce efficacy at (Table 1) . In animal models, azimilide has well-established fast heart rates as well as predispose to QT prolongation efficacy in the treatment of canine ischaemic and postand torsades de pointes at slow rates. There is no doubt myocardial infarction ventricular tachycardia and fibrillathat proarrhythmia is a major clinical concern with class III tion [4] [5] [6] as well as atrial flutter and vagally-induced agents (as highlighted by the SWORD study [1] ) and it has atrial fibrillation [7, 8] . Azimilide is now being evaluated in been postulated that multichannel blocking drugs (e.g. several large clinical trials for the treatment of supraventricular arrhythmias, as well as prevention of sudden cardiac death in post-MI patients with impaired left ventricular function [2, 9, 10] . [33, 37, 48, 49] 32 [12] ringer, Mannheim) and subcloned. 50 coverslips were placed at the bottom of a 0.5-ml perfusion chamber mounted on the stage of an inverted phase Ambasilide is an aminobenzoic acid derivative with a contrast microscope (Nikon Diaphot, Tokyo, Japan). Cells chemical structure similar to E-4031, which also lacks a were patched using micropipettes fabricated from thinmethanesulphonamide group [11, 12] . It prolongs APD and walled borosilicate glass (Vitrex Microhematocrit Tubes, ERP in the canine, rabbit and human atrium [11, 13, 14] as Modulohm I / S, Denmark) with a vertical pipette puller well as in the canine, guinea pig and human ventricle (Model 720, David Kopf Instruments, California, USA). [15] [16] [17] [18] . These effects are independent of stimulation Currents were amplified and filtered at 2 kHz with a 4-pole 1 frequency and extracellular [K ] [11, 13, [15] [16] [17] . The Bessel filter (23dB point) using an Axopatch 1D amplifier cellular mechanism for this activity is block of I and I , (Axon Instruments, Foster City, CA, USA). Stimulation Kr Ks 1 protocols and data acquisition were carried out using a as well as less potent inhibition of other cardiac K microcomputer (IBM pentium), running commercial softchannels (Table 1) .
ware and hardware (PCLAMP 6.0 / DIGIDATA 1200, Axon Human I is encoded by the human ether-a-go-goKr Instruments and Scientific Solutions). Whole-cell capacirelated gene (HERG) [19] and mutations of this gene may tance was determined from capacitative transient decay in cause the congenital long QT syndrome [20] . In this study, current recordings following voltage steps of 610 mV we compared the effects of these newer class III antiarfrom the holding potential. At least 80% series resistance rhythmic agents on the HERG channel. Initial experiments compensation was achieved in all reported experiments. focused on the effects of azimilide at room and physiological temperature, with particular attention to the kinetics of 2. prepared as stock solution in dimethylsulfoxide (DMSO), revised 1996). A detailed summary of experimental meththen subsequently diluted as required with superfusate ods has previously been published [21] .
(maximum final DMSO concentration of 0.1%, v / v). In preliminary experiments, we determined that 0.1% DMSO 2.1. Molecular biology (v / v) had no effect on the parameters under study Fig. 1D ). The after the step depolarization and the maximum reached at potency of block by ambasilide was voltage-dependent, the end of the step. Similarly, the tail current amplitude since the IC for tail current block at 230 mV was 16.1 50 was recorded as the difference between the peak and mM (95%CI 9.0-28.8 mM) with a Hill coefficient of steady state current after repolarization to 260 mV. In 20.860.2 (n54-11). experiments where tail currents did not fully relax to Currents elicited during step depolarizations ('activating steady state, the peak tail current amplitude was used in the currents') were inhibited by 1 mM azimilide at potentials analysis.
greater than 240 mV, but were augmented at 240 and The voltage-dependence of current activation was de-250 mV (n512, Figs. 1A and 2A) . Similarly, azimilide termined by fitting the values of the normalised tail inhibited tail currents at voltages above 240 mV, but currents to a Boltzmann function augmented current at more negative potentials (Fig. 2B ). This 'agonist effect' was use-dependent, since it was only 
Concentration-and voltage-dependence of HERG n59). channel inhibition
The I-V relationships for both activating and tail currents at baseline and after ambasilide 3 mM are shown We have previously reported that HERG channels stably in Fig. 3A tics to HERG expressed in Xenopus oocytes and other after ambasilide, respectively, n58), although there was a mammalian cell lines [19, [21] [22] [23] . Currents were elicited small difference in the slope factors (9.760.2 versus using step depolarizations to potentials between 250 and 12.260.5 mV, P,0.01, n58). We further assessed the 130 mV from a holding potential of 280 mV at room voltage-dependence of block by plotting relative tail temperature (228C). In Fig. 1A and B, representative current (I /I ) at each test potential. Current inhibition amb con currents are demonstrated at baseline, then during steady increased from 2066% at 240 mV to 4964% at 130 mV state blockade maintained by stimulation at 0.1 Hz in the (P,0.05, n58, Fig. 3C ). presence of 1 mM azimilide or 3 mM ambasilide. In experiments using 1 mM azimilide, current returned to 3.2. Effect of pulse duration on inhibition 92610% of baseline after a 10-min washout period (n56), whereas washout of 3 mM ambasilide was less complete
Using an envelope of tails protocol, peak tail currents (7762% of baseline current, n55). Azimilide inhibited were recorded after steps to 130 mV of increasing tail currents at 260 mV following a voltage step to 130 duration (20-400 ms) before and during exposure to mV with an IC of 610 nM (95%CI 510-730 nM) and azimilide 1 mM (Fig. 4A) . We used small incremental 50 Hill coefficient of 21.060.1 (n5 4-10, Fig. 1C ). There time-steps based on a previous report that binding reaches steady state relatively rapidly after channel activation [24] . controls, versus 5967 ms after azimilide, P,0.05, n59, HERG tail currents were normalised to the maximum Fig. 4B ) but not changed by ambasilide (t 144618 ms for control current and fitted with exponential functions. The controls and 103616 ms after ambasilide, P5ns, n512, time constant of channel activation determined using this Fig. 4D ). Inhibition by both drugs increased with pulse method was shortened by azimilide (t 9668 ms in duration and the development of block was fitted with a single exponential function yielding time constants of basilide was assessed using a protocol in which peak tail 144610 ms (n59, Fig. 4C ) for azimilide and 7964 ms for currents at 260 mV were recorded after each of a train of ambasilide (n56, Fig. 4E) . 0.5 s voltage steps to 130 mV, delivered at frequencies Since block did not reach steady state in the envelope of between 0.03 and 1 Hz. There was no significant change in tails protocol, we studied channel inhibition during a the control current during this protocol and inhibition by prolonged (15 s) depolarization to 110 mV in the presence ambasilide 3 mM did not differ after 2.5 min of stimulation of drug (Fig. 5A and B ). When relative current (I /I ) in (3761, 3664, 3363 and 4165% block with 0.03, 0.1, 0.5 az con the representative experiment was plotted on an expanded and 1 Hz stimulation, respectively, n54-12). time scale (Fig. 5C and D) , it was apparent that inhibition by azimilide and ambasilide occurred rapidly after channel 3.4. Modulation of activation and deactivation kinetics opening (t, 258 and 140 ms, respectively). Similar results were obtained in three different cells.
Time constants of activation were calculated by fitting a single exponential function to activating currents in Fig.  3.3 . Frequency-dependence of HERG channel block 1A. In agreement with the findings in Fig. 4 , there was a significant increase in the rate of channel activation A previous study showed that HERG channel inhibition following azimilide at most potentials (Fig. 6A) , whereas by azimilide exhibited reverse frequency-dependence for there was no change following ambasilide (Fig. 6B) . stimulation rates between 0.04 and 1 Hz [24] . The freWe studied the deactivation of tail currents produced by quency-dependence of channel blockade by 3 mM ama 3.9 s pulse to 130 mV followed by a 10-s repolarization to 260 mV (Fig. 7) . While azimilide did not affect tail demonstrates that inactivation was accelerated in the current kinetics, both fast and slow components of deactipresence of 1 mM azimilide at most potentials (e.g. t vation were significantly slower with ambasilide (t 14.261.1 ms before and 11.260.7 ms after azimilide at 889650 ms and 42576304 ms for controls versus t 240 mV, P,0.05, n57). Time constants of inactivation 14376121 ms and 71206520 ms with ambasilide, P, were modestly accelerated by ambasilide at potentials 0.01, n56, Fig. 7B ). The relative contribution of the fast between 240 and 220 mV, and not significantly affected component of deactivation was not modified by amat other potentials (data not shown, n59). basilide.
Recovery from inactivation was determined by fitting a single exponential function to the initial 'hook' preceding 3.5. Modulation of channel inactivation slower deactivation of tail currents at potentials between 2120 and 0 mV (elicited by a 500-ms step to 130 mV). Mutations at the S631 residue significantly weaken Azimilide (n512, Fig. 8C ) had minimal, and ambasilide inactivation and abolish current augmentation by azimilide (n55, data not shown) had no discernible effect on the [24] . We therefore expected that azimilide itself may have time constants of recovery from inactivation. effects on inactivation gating and voltage-dependence. A
The voltage dependence of steady-state inactivation was dual pulse protocol was used to assess the time course of assessed using the following protocol. Following a 1-s step channel inactivation (Fig. 8A) . A 500-ms depolarization to to 130 mV, 20 ms pulses were applied to potentials 130 mV was followed by a 40-ms hyperpolarizing step to between 2120 and 140 mV, followed by a second step to 280 mV to relieve rapid inactivation. A second pulse to 130 mV (Fig. 8D) . Peak currents (measured 3 ms after the potentials between 2100 and 140 mV was then used to onset of the pulse to allow for capacitance artefact) elicited elicit large currents which underwent rapid reinactivation.
by the second step to 130 mV were plotted as a function Time constants of inactivation were determined by fitting a of the potential of the preceding 20 ms step (Fig. 8E ). single exponential function to these currents. 270.361.6 mV (P,0.01, n59), while the slope factor approach here. A 500-ms voltage ramp from 140 to 280 remained unchanged. There was no change in the voltage mV was used to elicit currents such as those demonstrated dependence of inactivation in the presence of ambasilide 3 in Fig. 9A . At baseline, the HERG current peaked at 370 mM (V and slope 258.561.0 mV and 218.960.9 in ms into the ramp, corresponding to a membrane potential 1 / 2 controls versus 257.361.3 mV and 220.561.1 after of 248 mV (n510). After exposure to 1 mM azimilide, the ambasilide, n511). current peaked at 350 ms (membrane potential 244 mV, n56, Fig. 9B ). When relative current (derived from the 3.6. Voltage ramp protocol data in Fig. 9B ) was plotted as a function of membrane potential there was a non-significant trend towards inThe use of a ventricular action potential as the voltage creased block at negative membrane potentials (P5ns, Fig.  clamp command protocol has shed more light on the in 9C). vivo characteristics of the HERG channel [25, 26] . It has
The same ramp protocol was applied to cells at baseline been shown that very similar current traces and I-V and in the presence of ambasilide (Fig. 9D ). There was a relationships are produced by a 0.2-0.5 s descending modest shift in peak current from 244 mV at baseline to voltage ramp [25] , and, for convenience, we have used this 247 mV after 3 mM ambasilide (n56, Fig. 9E ). As with Fig. 9 . Voltage ramp protocol. (A) A 500-ms voltage ramp was used to simulate the repolarization during a cardiac action potential. Currents were recorded at baseline and during superfusion with 1 mM azimilide. Both increased steadily reaching a peak at 370 ms (control) and 350 ms (azimilide) and then declined more rapidly at more negative voltages due to deactivation. (B) I-V relationship for ramp experiments (n56). Currents were corrected for cell capacitance and every tenth point was plotted for clarity. After azimilide there was a small (14 mV) shift in peak current. (C) Relative current during voltage ramp protocol. Block was not strictly voltage-dependent, although there was a trend towards increased block at negative membrane potentials. (D) An identical voltage ramp was applied in experiments with 3 mM ambasilide. (E) I-V relationship for capacitance-corrected currents (n56). After the addition of 3 mM ambasilide, there was a modest (23 mV) shift in peak current. (F) Block increased during the ramp from 764% at the onset of the ramp to 4169% at the end of the ramp (P,0.01, n56).
azimilide, block increased as the ramp potential became potentiation' was lost when the same protocol was applied more negative from 764% at the onset of the ramp to to HERG channels with mutations at the outer mouth 4169% at the end of the ramp (P,0.01, Fig. 9F ).
(S631C) or S5-P loop regions (H587P), suggesting that the agonist site is in the extracellular domain [38] . Our studies confirmed that the agonist effect is present at membrane 4. Discussion potentials negative to 230 mV. The mechanism appears to be a concentration-dependent, hyperpolarizing shift in the Selective I blockade is associated with potent antifibvoltage-dependence of channel activation induced by Kr rillatory effects in the atria, but has not proven beneficial in azimilide. The changes in activation kinetics may also be the prevention of sudden death in post-myocardial infarcexplained by this shift in activation gating, since after tion patients [1, 27, 28] . Interest in multichannel blocking correction for the shift in the activation curve, we found drugs such as azimilide and ambasilide stems from clinical that only the time constants at 220 and 230 mV were studies showing that amiodarone has at least equal or significantly different from controls. Similar findings have greater efficacy than other antiarrhythmic drugs with a low been reported for the experimental class III agent almokalincidence of torsades de pointes [29, 30] . Preliminary ant, in which augmentation of I at near threshold Kr studies with azimilide suggest at least equivalent efficacy potentials was attributed to a hyperpolarizing shift in the to other class III antiarrhythmic drugs with a low incidence voltage-dependence of activation [39] . These findings of adverse cardiac events [2, 9, 10] . Although not in clinical provide further evidence for an interaction between the use, ambasilide is a useful investigational agent since it outer mouth and nearby extracellular domain and activablocks both components of I and has in vivo effects tion gating (S4 region) [38] .
K similar to amiodarone [13, 31] [24, [32] [33] [34] . Differences between the dependent between 230 and 130 mV, consistent with 50 properties of the oocyte membrane and mammalian cells previous reports of HERG and I inhibition in canine Kr may account for this discrepancy [26, 35] . We found that ventricular myocytes [24, 34] . Figs. 4 and 5 show that extra-cellular application of ambasilide blocked HERG inhibition required channel activation and exhibited timechannels with an IC of 3.6 mM, which is similar to the dependence (t 258 ms). Azimilide is known to increase the 50 potency of I block reported in guinea pig ventricular rate of I activation in AT-1 cells [24] . In agreement, we Kr Kr myocytes (IC of 2-5.6 mM) [12, 14] . found that time constants of channel activation obtained 50 Changes in temperature are known to affect the ERP and using the envelope of tails protocol were significantly frequency-dependence of class III antiarrhythmic activity accelerated in the presence of 1 mM azimilide, as were in papillary muscle preparations [36] . Azimilide clearly activation time constants obtained by direct exponential exhibits forward frequency-dependence at 378C (1-4 Hz), fitting of HERG currents elicited by a series of membrane but this effect is much less apparent at 328C [36] . Since the depolarizations. temperature at which recordings are made significantly Since recent data suggest that the HERG channel agonist modifies HERG channel properties and the blocking effect correlates with the degree of inward rectification potency of class III agents [26] , we repeated experiments [38, 40] , we examined the effect of azimilide on the time at 378C, finding little difference in the IC value. As course and voltage-dependence of channel inactivation. 50 expected, drug binding by azimilide was faster at 378C, but There was a significant acceleration in channel inactivation unbinding was slow and difficult to evaluate. We perat most potentials in the presence of 1 mM azimilide, but formed experiments with ambasilide at room temperature recovery from inactivation was minimally affected, and, in and it is possible that the inhibitory potency, frequencyaddition, there was a |10-mV hyperpolarizing shift in the dependence and binding kinetics may be different at 378C, voltage-dependence of inactivation. This shift represents a since the greatest effect of temperature is on HERG reduction in channel availability although such an effect activation kinetics followed by inactivation and deactivawould be significantly attenuated by the hyperpolarizing tion [26] .
shift in the voltage-dependence of activation. It also suggests that azimilide has affinity for the inactivated 4. myocytes at low concentrations (50-100 nM), in particular that affinity for the S631A mutant (a point mutation which at near threshold potentials [37] . A recent report described greatly reduces HERG channel inactivation), did not differ a use-dependent HERG channel agonist effect at 250 mV from that for wild-type HERG channels [24, 38] . The in the presence of 5 mM azimilide [38] . This 'prepulse reason for this disparity is not clear but may relate to [5, 47] , its Inhibition of HERG channels by ambasilide exhibited propensity to cause QT prolongation and torsades de voltage-and time-dependence similar to azimilide, but was pointes in humans remains undefined. While an agonist not frequency-dependent. Block was greater at positive effect was not apparent during a single voltage ramp it potentials consistent with binding of a positively charged may have significance in the setting of a delayed aftercomponent of the drug to a site within the transmembrane depolarization or in partially depolarized tissue (e.g. iselectrical field. The pK of ambasilide is 6.5 (personal chaemia) in which I potentiation may occur [38] .
a Kr communication: E. Schneider, Knoll, Milan, Italy) which The human therapeutic plasma concentration of ammeans that |13% is positively-charged at pH 7.4. The time basilide has not been reported, however, in a dog model, it course of HERG channel activation was not modified by was approximately 15 mM [13] . This concentration would ambasilide, however, time constants of deactivation were clearly inhibit I , but would also have significant effects Kr 1 significantly prolonged in comparison with controls. This on other cardiac K channels (see Table 1 ). The complex is also observed with I inhibition by ibutilide and electrophysiological effects of ambasilide in the human [25, 26, 46] . Azimilide caused only a small (14 
